Congress’s Absurd Insider Trading Bill

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published

Invalid Image
This has been said before, but it is worth saying again. The idea that Congress needs to pass a bill to keep members of Congress and their staffs from insider trading is the reason Americans have no confidence in the institution. It is tantamount to passing a bill that says members of Congress cannot sell illegal drugs on the floor of the House or Senate.

The new legislation, called the Stop Trading on Congressional Knowledge Act, was passed in the Senate by a margin of 96 to 3. It now goes to the House for what is an almost certain passage there. The president then gets to sign a bill that says that people should not do something they know not to do.

Insider trading is one of the most widely covered subjects about Wall St. That means that no one who follows the subject in the media could be in the dark. This has been particularly true since Galleon Group hedge fund founder Raj Rajaratnam went to jail and former Goldman Sachs director and past head of McKinsey & Co. Rajat K. Gupta was charged due to evidence each used information he should not have used to try to make money in the stock market.

Some experts argue that insider trading laws are open to wide interpretations. The head of one of the largest hedge funds, Steven A. Cohen of SAC Capital Advisors, recently said that insider trading has to be examined on a case-by-case basis. He knows it if he sees it, but has no objective means of measurement. That argument is spurious. Cohen has been around Wall St. long enough to know when he is even close to the white line.

Congress members and their staffs know better, too. They receive mounds of information about decisions and data that could affect the values of public companies. The rule, even if it is not put down in law for them to follow, is that if you can make money that people without the information cannot, it is illegal and unethical. And it is also one of the roots of the national confidence in the federal legislative institutions.

All of that is worth saying, again.

Douglas A. McIntyre

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

KMX Vol: 7,330,419
GLW Vol: 22,800,969
INTC Vol: 233,719,006
SMCI Vol: 68,465,534
ENPH Vol: 13,978,376

Top Losing Stocks

ACN Vol: 41,744,333
EPAM Vol: 5,636,587
CTSH Vol: 61,311,400
CTRA Vol: 73,319,495
KR Vol: 26,704,230